Concepedia

Holly LaDuca

HL

51

Publications

4.5K

Citations

34

H-Index

2009

Active since

Affiliations

Ambry Genetics (United States)(Current)

University of California, Irvine

Mayo Clinic in Arizona

University of Utah

Dana-Farber Cancer Institute

Holly LaDuca is an author at Ambry Genetics (United States) specializing in medicine, genetics, and oncology.

ORCID

Top concepts

Publications per year

2009–2023

51

Publications

51

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

Fergus J. Couch, Hermela Shimelis, Chunling Hu et al. · JAMA Oncology · 2017 · 615 citations · Full text

Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk et al. · Journal of Clinical Oncology · 2019 · 393 citations · Full text

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients

Holly LaDuca, Aaron J. Stuenkel, Jill S. Dolinsky et al. · Genetics in Medicine · 2014 · 335 citations · Full text

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing

Hermela Shimelis, Holly LaDuca, Chunling Hu et al. · JNCI Journal of the National Cancer Institute · 2018 · 312 citations · Full text

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care

Stephany Tandy-Connor, Jenna Guiltinan, Kate Krempely et al. · Genetics in Medicine · 2018 · 261 citations · Full text

Rows per page

1–5 of 51